Patheon has entered a sales and marketing agreement with Italy's BSP Pharmaceuticals, a developer and manufacturer of cytotoxic pharmaceutical products. Patheon will promote BSP's cytotoxic manufacturing capacity and development services and Aldo Braca, president, Patheon Europe, will serve as president and chief executive officer of BSP Pharmaceuticals until a successor [...]

Amgen was buoyed by the news that new data demonstrates that motesanib slowed the progression of metastatic thyroid cancer. Out of 93 patients in the study, 49 had a positive response. Volunteers with a BRAF V600E mutation did better than those without the mutation. Report[...]

The Food and Drug Administration said Adolor Corp. could resume clinical testing of its drug Entereg to treat bowel discomfort commonly associated with use of opioid painkillers, the Exton company said today.[...]

APP Pharmaceuticals Inc. said Thursday it received final approval from the Food and Drug Administration to market its granisetron hydrochloride injection, the generic version of Hoffmann-LaRoche's Kytril injection for chemo-induced nausea. Read More Permalink[...]

Carlisle Companies Incorporated (CSL) engages in the manufacture and sale of construction materials in the United States and internationally. It operates in five segments: Construction Materials, Industrial Components, Transportation Products, Specialty Products, and General Industry. The company is not a dividend aristocrat but a dividend champion. In fact, this stock [...]

A Harvard University professor defended research suggesting the FDA was too hasty in approving drug, which the agency has criticized as mistaken, The Wall Street Journal writes. The professor, Daniel Carpenter, acknowledged that the FDA had identified mistakes in his study, which was published by the New England Journal of [...]